333 related articles for article (PubMed ID: 12593610)
1. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma.
Galanaud D; Chinot O; Nicoli F; Confort-Gouny S; Le Fur Y; Barrie-Attarian M; Ranjeva JP; Fuentès S; Viout P; Figarella-Branger D; Cozzone PJ
J Neurosurg; 2003 Feb; 98(2):269-76. PubMed ID: 12593610
[TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
3. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
4. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy.
Yerli H; Ağildere AM; Ozen O; Geyik E; Atalay B; Elhan AH
Diagn Interv Radiol; 2007 Mar; 13(1):3-9. PubMed ID: 17354186
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopy-guided biopsy for cerebral glial tumors.
Chen CY; Lirng JF; Chan WP; Fang CL
J Formos Med Assoc; 2004 Jun; 103(6):448-58. PubMed ID: 15278190
[TBL] [Abstract][Full Text] [Related]
7. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
Floeth FW; Pauleit D; Wittsack HJ; Langen KJ; Reifenberger G; Hamacher K; Messing-Jünger M; Zilles K; Weber F; Stummer W; Steiger HJ; Woebker G; Müller HW; Coenen H; Sabel M
J Neurosurg; 2005 Feb; 102(2):318-27. PubMed ID: 15739561
[TBL] [Abstract][Full Text] [Related]
8. MR spectroscopy in gliomatosis cerebri.
Bendszus M; Warmuth-Metz M; Klein R; Burger R; Schichor C; Tonn JC; Solymosi L
AJNR Am J Neuroradiol; 2000 Feb; 21(2):375-80. PubMed ID: 10696026
[TBL] [Abstract][Full Text] [Related]
9. Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy.
Vuori K; Kankaanranta L; Häkkinen AM; Gaily E; Valanne L; Granström ML; Joensuu H; Blomstedt G; Paetau A; Lundbom N
Radiology; 2004 Mar; 230(3):703-8. PubMed ID: 14739313
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopic imaging of cerebral gliomas: correlation of metabolite ratios with histopathologic grading.
Hsu YY; Chang CN; Wie KJ; Lim KE; Hsu WC; Jung SM
Chang Gung Med J; 2004 Jun; 27(6):399-407. PubMed ID: 15455540
[TBL] [Abstract][Full Text] [Related]
11. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
12. Value of diagnosis and differential diagnosis of MRI and MR spectroscopy in gliomatosis cerebri.
Yu A; Li K; Li H
Eur J Radiol; 2006 Aug; 59(2):216-21. PubMed ID: 16769190
[TBL] [Abstract][Full Text] [Related]
13. Proton MR spectroscopy of gliomatosis cerebri: case report of elevated myoinositol with normal choline levels.
Saraf-Lavi E; Bowen BC; Pattany PM; Sklar EM; Murdoch JB; Petito CK
AJNR Am J Neuroradiol; 2003 May; 24(5):946-51. PubMed ID: 12748099
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance spectroscopy detection of high lipid levels in intraaxial tumors without central necrosis: a characteristic of malignant lymphoma.
Yamasaki F; Takayasu T; Nosaka R; Amatya VJ; Doskaliyev A; Akiyama Y; Tominaga A; Takeshima Y; Sugiyama K; Kurisu K
J Neurosurg; 2015 Jun; 122(6):1370-9. PubMed ID: 25748300
[TBL] [Abstract][Full Text] [Related]
15. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O
Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
[TBL] [Abstract][Full Text] [Related]
16. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
[TBL] [Abstract][Full Text] [Related]
17. Advanced MR imaging techniques in the evaluation of nonenhancing gliomas: perfusion-weighted imaging compared with proton magnetic resonance spectroscopy and tumor grade.
Sahin N; Melhem ER; Wang S; Krejza J; Poptani H; Chawla S; Verma G
Neuroradiol J; 2013 Oct; 26(5):531-41. PubMed ID: 24199813
[TBL] [Abstract][Full Text] [Related]
18. Proton MR spectroscopy in predicting the increase of perfusion MR imaging for WHO grade II gliomas.
Guillevin R; Menuel C; Abud L; Costalat R; Capelle L; Hoang-Xuan K; Habas C; Chiras J; Vallée JN
J Magn Reson Imaging; 2012 Mar; 35(3):543-50. PubMed ID: 22045581
[TBL] [Abstract][Full Text] [Related]
19. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y
Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899
[TBL] [Abstract][Full Text] [Related]
20. 3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature.
Caivano R; Lotumolo A; Rabasco P; Zandolino A; D'Antuono F; Villonio A; Lancellotti MI; Macarini L; Cammarota A
Int J Neurosci; 2013 Aug; 123(8):537-43. PubMed ID: 23390934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
